NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Viveon Health Acquisition Corp. (VHAQ.WS)
NEW YORK, October 24, 2023--(BUSINESS WIRE)--NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants of Viveon Health Acquisition Corp. (the "Company") — ticker symbol VHAQ.WS — from the NYSE American. Trading in the Company’s warrants will be suspended immediately. Trading in the Company’s common stock — ticker symbol VHAQ — and units — ticker symbol VHAQ.U — will continue on the NYSE American.
NYSE Regulation has determined that the Company’s warrants are no longer suitable for listing pursuant to Section 1001 of the NYSE American Company Guide due to the low trading price of such warrants.
The Company has a right to a review of staff’s determination to delist the Company’s warrants by a Committee of the Board of Directors of the Exchange. The NYSE American will apply to the Securities and Exchange Commission to delist the Company’s warrants upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231024511901/en/
Contacts
Company Contacts:
Rom Papadopoulos
Chief Financial Officer
Viveon Health Acquisition Corporation
rom@viveonhealth.com
Investor Relations
Ginny Connolly
Clearday Inc.
info@myclearday.com
210-451-0839
NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com
